GB1419969A - Immunostimulant agent compositions thereof and methods for their preparation - Google Patents

Immunostimulant agent compositions thereof and methods for their preparation

Info

Publication number
GB1419969A
GB1419969A GB5916472A GB5916472A GB1419969A GB 1419969 A GB1419969 A GB 1419969A GB 5916472 A GB5916472 A GB 5916472A GB 5916472 A GB5916472 A GB 5916472A GB 1419969 A GB1419969 A GB 1419969A
Authority
GB
United Kingdom
Prior art keywords
cells
chloroform
immunostimulating agent
saline
solid residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5916472A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of GB1419969A publication Critical patent/GB1419969A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB5916472A 1971-12-24 1972-12-21 Immunostimulant agent compositions thereof and methods for their preparation Expired GB1419969A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7146520A FR2164510B1 (cg-RX-API-DMAC10.html) 1971-12-24 1971-12-24

Publications (1)

Publication Number Publication Date
GB1419969A true GB1419969A (en) 1975-12-31

Family

ID=9088030

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5916472A Expired GB1419969A (en) 1971-12-24 1972-12-21 Immunostimulant agent compositions thereof and methods for their preparation

Country Status (15)

Country Link
JP (1) JPS4868729A (cg-RX-API-DMAC10.html)
AR (1) AR195897A1 (cg-RX-API-DMAC10.html)
BE (1) BE793260A (cg-RX-API-DMAC10.html)
CA (1) CA991543A (cg-RX-API-DMAC10.html)
CS (1) CS190380B2 (cg-RX-API-DMAC10.html)
DE (1) DE2262427C3 (cg-RX-API-DMAC10.html)
DK (1) DK137887B (cg-RX-API-DMAC10.html)
ES (1) ES410435A1 (cg-RX-API-DMAC10.html)
FR (1) FR2164510B1 (cg-RX-API-DMAC10.html)
GB (1) GB1419969A (cg-RX-API-DMAC10.html)
IL (1) IL41120A (cg-RX-API-DMAC10.html)
NL (1) NL7217588A (cg-RX-API-DMAC10.html)
PL (1) PL89687B1 (cg-RX-API-DMAC10.html)
SU (1) SU592333A3 (cg-RX-API-DMAC10.html)
ZA (1) ZA728959B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111642460A (zh) * 2020-06-23 2020-09-11 山西省中医药研究院(山西省中医院) 松果体损伤大鼠模型的构建方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2257266B1 (cg-RX-API-DMAC10.html) 1974-01-10 1977-07-01 Pasteur Institut
FR2287901A1 (fr) * 1974-10-14 1976-05-14 Pasteur Institut Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle
JPS5835121A (ja) * 1981-08-20 1983-03-01 ビラス・ヴィー・リクハイト 免疫刺激性補助剤からなる抗原及び免疫療法におけるその使用
CA1225592A (en) * 1983-08-26 1987-08-18 Ribi Immunochem Research Inc. Refined detoxified endotoxin
IT1186793B (it) * 1985-11-26 1987-12-16 Sibar Srl Frazione ottenuta da listeria monocytogenes avente attivita' terapeutica,procedimento per la sua preparazione e composioni farmaceutiche che la contengono
JPH02131433A (ja) * 1988-11-11 1990-05-21 Nisshin Flour Milling Co Ltd 非特異的感染予防・治療剤
EP3150323B1 (en) 2015-09-30 2020-11-18 Kabushiki Kaisha Toshiba Laser processing apparatus, laser processing method and distance measurement method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU57091A1 (cg-RX-API-DMAC10.html) * 1968-10-15 1970-04-16

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111642460A (zh) * 2020-06-23 2020-09-11 山西省中医药研究院(山西省中医院) 松果体损伤大鼠模型的构建方法

Also Published As

Publication number Publication date
JPS4868729A (cg-RX-API-DMAC10.html) 1973-09-19
PL89687B1 (en) 1976-12-31
BE793260A (fr) 1973-06-22
FR2164510B1 (cg-RX-API-DMAC10.html) 1975-02-07
DE2262427A1 (de) 1973-07-12
DK137887C (cg-RX-API-DMAC10.html) 1978-10-16
AR195897A1 (es) 1973-11-15
DE2262427C3 (de) 1980-04-24
ES410435A1 (es) 1976-01-01
CS190380B2 (en) 1979-05-31
DK137887B (da) 1978-05-29
SU592333A3 (ru) 1978-02-05
IL41120A0 (en) 1973-02-28
CA991543A (en) 1976-06-22
IL41120A (en) 1975-12-31
ZA728959B (en) 1973-09-26
FR2164510A1 (cg-RX-API-DMAC10.html) 1973-08-03
NL7217588A (cg-RX-API-DMAC10.html) 1973-06-26
DE2262427B2 (de) 1979-08-09

Similar Documents

Publication Publication Date Title
US10946048B2 (en) Use of gram negative species to treat atopic dermatitis
EP0165726A2 (en) Intestinal microflora-improving agent
HAYAKAWA et al. The ilicicolins, antibiotics from Cylindrocladium ilicicola
KR20190134563A (ko) 락토바실러스 아시도필루스를 포함하는 관절염, 섬유증, 대장염 또는 이식거부 반응의 예방 또는 치료용 조성물
US4243663A (en) Glycolipid compositions for transplanted tumor immunotherapy
US3331741A (en) Process for the preparation of a soluble bacterial extract
ES410435A1 (es) Procedimiento de preparacion de inmunoestimulantes.
EP0216934A1 (en) Novel tumor necrosis factor-inducing substance originating in acid-fast bacteria
GB1502348A (en) Water soluble acetylated bacterial extracts containing diaminopimelic acid obtained from corynebacteria
US3767799A (en) Antibiotic proticin
Mokyr et al. Ability of cyclophosphamide in the absence of cross-linking activity to exert the immunomodulatory effect required for the cure of mice bearing a large MOPC-315 tumor
Hamasaki On the Properties of an Established Cell Strain, JTC-11, from Ehrlich Ascites Tumor in Tissue Culture Part 1 The Characteristics of the Standard Strain (K-Strain)
JPS5558203A (en) Hard polyvinyl alcohol gel and its preparation
ES268859A1 (es) Procedimiento para la obtenciën de nuevos derivados de pirazina
MX2022000824A (es) Composicion cosmetica para el cuidado de la piel.
Tsukamura et al. Effect of Adenine on Tuberculous Infection and BCG Vaccination in Mice
Ando et al. STUDIES ON THE EFFECT OF TWEEN 80 ON THE GROWTH OF ERYSIPELOTHRIX LNCIDIOSA
JPS6153219A (ja) 抗腫瘍剤
KODAMA et al. Bacteria isolated from silkworm larvae IX. The behavior of antibiotics added to an artificial diet
CN104257640A (zh) 一种紫檀芪组合物及其制备方法
GB1430157A (en) Methods and compositions for inducing resistance to bacterial infections
SATO Drug-resistance and Distribution of R Factors among Escherichia coli Strains Isolated from Pork
Mueller Amino Acids Required by the Diphtheria Bacillus for Growth
GB1359118A (en) Pharmaceutical tablets
OKOTI STUDIES ON THE NUTRITION OF LUMINOUS BACTERIA IV. COMPARATIVE EXPERIMENTS BETWEEN NATURAL AND SYNTHETIC MEDIA

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee